Get the Stockscreener App
156.30
4.92%
-8.0956
After Hours:
156.30
First Trust Nyse Arca Biotechnology Index Fund stock is traded at $156.30, with a volume of 33,222.
It is down -4.92% in the last 24 hours and up +2.32% over the past month.
See More
Previous Close:
$164.40
Open:
$162.19
24h Volume:
33,222
Relative Volume:
1.39
Market Cap:
$3.19B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.65%
1M Performance:
+2.32%
6M Performance:
-11.53%
1Y Performance:
+5.30%
1-Day Range:
$155.32
$162.56
1-Week Range:
$155.32
$165.25
52-Week Range:
$141.38
$183.59
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Company Profile
Name
First Trust Nyse Arca Biotechnology Index Fund
Sector
Industry
Phone
-
Address
-
Compare FBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBT
First Trust Nyse Arca Biotechnology Index Fund
|
156.30 | 3.19B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
274.97 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
558.80 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
561.54 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
219.18 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
481.41 | 124.43B | 0 | 0 | 0 | 0.00 |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Latest News
How to Take Advantage of moves in (FBT) - news.stocktradersdaily.com
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
Eli Lilly and Co (NYSE:LLY): Promising Breakthrough in Weight-Loss Treatments - Value The Markets
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Learn to Evaluate (FBT) using the Charts - news.stocktradersdaily.com
StockWatch: Trump Tariffs Take Biopharma on a Roller Coaster Ride - Genetic Engineering and Biotechnology News
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now - Genetic Engineering and Biotechnology News
Monday's ETF Movers: FBT, XBI - Nasdaq
Where are the Opportunities in (FBT) - news.stocktradersdaily.com
Healthcare Sector Trying To Bounce Back - Seeking Alpha
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value The Markets
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(FBT) Trading Advice - Stock Traders Daily
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
First Trust Nyse Arca Biotech Etf (FBT) - INDmoney
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds - br.ADVFN.com
(FBT) Investment Report - Stock Traders Daily
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
How To Trade (FBT) - Stock Traders Daily
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Should You Invest in the iShares Biotechnology ETF (IBB)? - TradingView
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - TradingView
(FBT) Trading Report - Stock Traders Daily
(FBT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
LifeSci Capital Initiates Coverage of Biotech Exchange Traded Funds (ETFs) - AccessWire
When the Price of (FBT) Talks, People Listen - Stock Traders Daily
XBI: 3 Biotech ETFs for Diversified Innovation Exposure - StockNews.com
This Warren Buffett-Owned ETF Threatens SPY's Dominance - Inkl
Vanguard's S&P 500 ETF Hits $100 Billion Inflows In 2024: Is SPY's Crown At Risk? - Inkl
(FBT) Long Term Investment Analysis - Stock Traders Daily
Top 5 Life Science ETFs in 2024 - Investing News Network
Hedge funds were net buyers of financials, healthcare for week: Goldman Sachs - MSN
FBT Crowded With Sellers - Nasdaq
5 Biggest Biotechnology ETFs in 2024 - Nasdaq
(FBT) Technical Data - Stock Traders Daily
Analysts Forecast 26% Upside For FBT - Nasdaq
Is Semaglutide a Band-Aid, or a Solution? - Securities.io
Best Biotech ETFs to Watch Right Now - The Motley Fool
Training The Immune System To Attack Cancer With Probiotics - Securities.io
New mRNA Vaccine Could Tackle Antibiotic Resistant C. difficile Infections - Securities.io
Coffee crowned king of commodities - New Zealand Herald
Fighting Cancer with BioTech – Why mRNA Vaccines Are Such a Leap Forward - Securities.io
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Financials Data
There is no financial data for First Trust Nyse Arca Biotechnology Index Fund (FBT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):